Daxor Corporation (DXR)
DXR Stock Price Chart
Explore Daxor Corporation interactive price chart. Choose custom timeframes to analyze DXR price movements and trends.
DXR Company Profile
Discover essential business fundamentals and corporate details for Daxor Corporation (DXR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
25 Jul 1983
Employees
37.00
Website
https://www.daxor.comCEO
Michael Richard Feldschuh
Description
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
DXR Financial Timeline
Browse a chronological timeline of Daxor Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 Mar 2026
Earnings released on 29 Aug 2025
Earnings released on 6 Mar 2025
Earnings released on 29 Jun 2024
EPS came in at -$0.34 , while revenue for the quarter reached $71.76K .
Earnings released on 16 May 2024
EPS came in at $0.72 , while revenue for the quarter reached $82.45K .
Earnings released on 28 Aug 2023
EPS came in at -$0.32 , while revenue for the quarter reached $80.97K .
Earnings released on 1 Mar 2023
EPS came in at $0.82 , while revenue for the quarter reached $96.40K , missing expectations by -99.76%.
Earnings released on 25 Aug 2022
EPS came in at -$0.22 , while revenue for the quarter reached $135.24K , missing expectations by -98.26%.
Earnings released on 15 May 2022
EPS came in at $0.78 , while revenue for the quarter reached $152.44K .
Earnings released on 15 Nov 2021
EPS came in at -$0.19 , while revenue for the quarter reached $125.65K .
Earnings released on 15 May 2021
EPS came in at $0.23 surpassing the estimated $0.10 by +128.40%, while revenue for the quarter reached $145.49K , missing expectations by -95.96%.
Earnings released on 15 Nov 2020
EPS came in at -$0.85 falling short of the estimated $0.05 by -1.80K%, while revenue for the quarter reached $118.95K , missing expectations by -95.98%.
DXR Stock Performance
Access detailed DXR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.